AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology

Smith, Sidney C., Blair, Steven N., Bonow, Robert O., Brass, Lawrence M., Cerqueira, Manuel D., Dracup, Kathleen, Fuster, Valentin, Gotto, Antonio +12 more·2001·Circulation
DOI 10.1161/hc3801.097475

Cited by (661)

Items 301–400 of 661

  1. Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease
    Kim Michael Fox, Michel E. Bertrand, Willem J. Remme, Roberto Ferrari, Maarten L. Simoons, Jaap Willem Deckers · 2007 · American Heart Journal
  2. Secondary prevention programme of ischaemic heart disease in the elderly: A randomised clinical trial
    Elisenda Marcos-Forniol, José Félix Meco, Emili Corbella, Francesç Formiga, Xavier Pintó · 2017 · European Journal of Preventive Cardiology
  3. Documento de Consenso de Expertos sobre bloqueadores de los receptores ß-adrenérgicos
    Grupo de Trabajo sobre Bloqueadores Beta, de la Sociedad Europea de Cardiología · 2005 · Revista Española de Cardiología
  4. Aspirin Use in Chronic Heart Failure
    Barry M. Massie · 2005 · Journal of the American College of Cardiology
  5. Lipids and Stroke: The Opportunity of Lipid-Lowering Treatment
    José Vivancos Mora, Antonio Gil-Núñez · 2005 · Cerebrovascular Diseases
  6. ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction.
    Denise Lynn Campbell-Scherer, Lee A. Green · 2009 · PubMed
  7. Development and first assessment of a questionnaire for health care utilization and costs for cardiac patients
    Bernd Schweikert, Harry Hahmann, Reiner Leidl · 2008 · BMC Health Services Research
  8. Contemporary trends in cardiac rehabilitation in Germany: patient characteristics, drug treatment, and risk-factor management from 2000 to 2005
    Kurt P Bestehorn, Karl Wegscheider, Heinz Völler · 2008 · European Journal of Cardiovascular Prevention & Rehabilitation
  9. Peripheral Arterial Occlusive Disease: Magnetic Resonance Imaging and the Role of Aggressive Medical Management
    Alan B. Lumsden, Terry W. Rice, Changyi Chen, Wei Zhou, Peter H. Lin, Paul F. Bray, Joel D. Morrisett, Vijay Nambi, Christie Mitchell Ballantyne · 2007 · World Journal of Surgery
  10. Perceptions of Canadian Vascular Surgeons toward Pharmacological Risk Reduction in Patients with Peripheral Arterial Disease
    M. Al-Omran, T. Lindsay, J. Major, A. Jawas, L. Leiter, S. Verma · 2006 · Annals of Vascular Surgery
  11. Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatment
    Shigemasa Tani, Ken Nagao, Takeo Anazawa, Hirofumi Kawamata, Kiyoshi Iida, Michiaki Matsumoto, Yuichi Sato, Atsushi Hirayama · 2008 · Atherosclerosis
  12. Patency of infarct related artery after pharmacological reperfusion during transfer to primary percutaneous coronary intervention influences left ventricular function and one-year clinical outcome
    Dariusz Dudek, Tomasz Rakowski, Nader El‐Massri, Danuta Sorysz, J Zalewski, Jacek Legutko, Artur Dziewierz, Łukasz Rzeszutko, Krzysztof F. Zmudka, W Piwowarska et al. · 2007 · International Journal of Cardiology
  13. Características de los pacientes con cardiopatías en un área sanitaria de la provincia de A Coruña. Estudio Barbanza 2000
    José Ramón González‐Juanatey · 2003 · Revista Clínica Española
  14. Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial
    J. A. Black, S. Sharp, N. Wareham, A. Sandbaek, G. Rutten, T. Lauritzen, K. Khunti, Melanie J. Davies, K. Borch-Johnsen, S. Griffin et al. · 2014 · Diabetic Medicine
  15. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events
    Laura A. Fortuna, Pamala A. Pawloski, Emily D. Parker, Nicole K. Trower, Thomas E. Kottke · 2015 · European Heart Journal - Cardiovascular Pharmacotherapy
  16. The influence of polyvascular disease on the obesity paradox in vascular surgery patients.
    J. van Kuijk, W. Flu, Wael Galal, M. Chonchol, D. Goei, H. Verhagen, Jeroen J. Bax, D. Poldermans · 2011 · Journal of Vascular Surgery
  17. Number of teeth and myocardial infarction and stroke among elderly never smokers
    Anna-Maija Hannele Syrjälä, Pekka Ylöstalo, Sirpa A. Hartikainen, Raimo O. Sulkava, Matti L.E. Knuuttila · 2009 · Journal of Negative Results in BioMedicine
  18. Ramipril
    Vanessa R Anderson, Caroline M. Perry, Dean M Robinson · 2006 · American Journal of Cardiovascular Drugs
  19. Effect of drug combinations on admission for recurrent myocardial infarction
    Menno E. van der Elst, Marcel L. Bouvy, Cornelis J De Blaey, Anthonius de Boer · 2007 · Heart
  20. Evidence-based medicine in managed care: a survey of current and emerging strategies.
    Paul H Keckley · 2004 · PubMed Central
  21. Cardiac rehabilitation secondary prevention programs
    Lisa Womack · 2003 · Clinics in Sports Medicine
  22. Quinapril
    Christine R. Culy, Blair Jarvis · 2002 · Drugs
  23. Aligning Financial Incentives with Quality of Care in the Hospital Setting
    John T Berthiaume, Richard S. Cluing, Kirn L. Ryskina, Jim Walsh, Antonio P. Legorreta · 2006 · Journal for Healthcare Quality
  24. Genetic predisposition to coronary heart disease and stroke using an additive genetic risk score: A population-based study in Greece
    Nikos Yiannakouris, Michail Katsoulis, Vardis Dilis, Laurence D. Parnell, Dimitrios Trichopoulos, José María Ordovás, Antonia Trichopoulou · 2012 · Atherosclerosis
  25. Task Force #5—the role of cardiovascular specialists as leaders in prevention: from training to champion
    C. Noel Bairey Merz, George A. Mensah, Valentı́n Fuster, Philip Greenland, Paul D. Thompson · 2002 · Journal of the American College of Cardiology
  26. Mild Head Trauma: Is Antiplatelet Therapy a Risk Factor for Hemorrhagic Complications?
    Gabriele Savioli, Iride Francesca Ceresa, Sabino Luzzi, Alice Giotta Lucifero, Maria Serena Pioli Di Marco, Federica Manzoni, Lorenzo Preda, Giovanni Ricevuti, Maria Antonietta Bressan · 2021 · Medicina
  27. Effect of cardiac rehabilitation program on exercise capacity in women undergoing coronary artery bypass graft in hamadan-iran.
    Ramin Shabani, Abas A Gaeini, Mohamad R Nikoo, Hojatollah Nikbackt, Majid Sadegifar · 2010 · Europe PMC (PubMed Central)
  28. Cardiovascular Outcomes for Obesity and Metabolic Syndrome
    Gloria Lena Vega · 2002 · Obesity Research
  29. Relation of Change in Apolipoprotein B/Apolipoprotein A-I Ratio to Coronary Plaque Regression After Pravastatin Treatment in Patients With Coronary Artery Disease
    Shigemasa Tani, Ken Nagao, Takeo Anazawa, Hirofumi Kawamata, Shingo Furuya, Hiroshi Takahashi, Kiyoshi Iida, Michiaki Matsumoto, Takehiko Washio, Narimichi Kumabe et al. · 2010 · The American Journal of Cardiology
  30. Effects of β-Blockers and Anxiety on Complication Rates After Acute Myocardial Infarction
    Mohannad Eid AbuRuz, Terry A. Lennie, Debra Kay Moser · 2010 · American Journal of Critical Care
  31. Protective Effects of Pinus halepensis L. Essential Oil on Aspirin-induced Acute Liver and Kidney Damage in Female Wistar Albino Rats
    Hafsia Bouzenna, Noura Samout, Etaya Amani, Sakhria Mbarki, Zied Tlili, Ilhem Rjeibi, Abdelfattah Elfeki, Hélène Talarmin, Najla Hfaïedh · 2016 · Journal of Oleo Science
  32. A Randomized Clinical Trial of Secondary Prevention Among Women Hospitalized with Coronary Heart Disease
    Lori J. Mosca, Allison H. Christian, Heidi Mochari Greenberger, Paul Kligfield, Sidney C. Smith · 2010 · Journal of Women s Health
  33. Different Contributions of Physical Activity on Arterial Stiffness between Diabetics and Non-Diabetics
    Takeshi Iwasa, Eisuke Amiya, Jiro Ando, Masafumi Watanabe, Takahide Murasawa, Issei Komuro · 2016 · PLoS ONE
  34. Myocardial perfusion imaging (MPI) is superior to the demonstration of distal collaterals in predicting cardiac events in chronic total occlusion (CTO)
    Samuel Wright, Meir Lichtenstein, Leeanne Grigg, Dinesh A. Sivaratnam · 2013 · Journal of Nuclear Cardiology
  35. Effect of Obesity on Coronary Atherosclerosis and Outcomes of Percutaneous Coronary Intervention
    Soo‐Jin Kang, Gary S. Mintz, Bernhard Witzenbichler, David Christopher Metzger, Michael J. Rinaldi, Peter L. Duffy, Giora Weisz, Thomas Stuckey, Bruce R. Brodie, Takehisa Shimizu et al. · 2015 · Circulation Cardiovascular Interventions
  36. Medical Management of Peripheral Arterial Disease: A Therapeutic Algorithm
    Alan B. Lumsden, Terry W. Rice · 2006 · Journal of Endovascular Therapy
  37. Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease
    M. Teresa Santos, Juana Vallés, Justo Aznar, Aida Pilar Lago, Elena Sánchez, Juan Cosín, Antonio Moscardó, Marta Piñón, Marinus Johan Broekman, Aaron J. Marcus · 2006 · Journal of Laboratory and Clinical Medicine
  38. Sleeve Gastrectomy Reduces Blood Pressure in Obese (fa/fa) Zucker Rats
    Amaia Rodrı́guez, Sara Becerril, Víctor Valentí, Beatriz Ramírez, Marina Martín, Leire Méndez-Giménez, Andoni Lancha, Pablo del Sol Calderón, Victoria Catalán, Marı́a A. Burrell et al. · 2011 · Obesity Surgery
  39. Factors predicting discontinuation of a hospital-based cardiac rehabilitation programme.
    Abbas Soleimani, Ali Abbasi, Mostafa Nejatian, Mojtaba Salarifar, Siroos Darabian, Abbasali Karimi, Saeed Davoodi, Seyed Ebrahim Kassaian, Seyed Hesameddin Abbasi, Mahmood Sheikhfathollahi · 2009 · PubMed
  40. Effects of an enhanced secondary prevention program for patients with heart disease: A prospective randomized trial
    Steven M. Edworthy, Bonnie Baptie, Donna Galvin, Rollin Brant, Terry Churchill-Smith, Dante E. Manyari, Israel Belenkie · 2007 · Canadian Journal of Cardiology
  41. Inercia terapéutica en prevención secundaria de enfermedad cardiovascular. Registro FRENA
    Leonor Roa, Manuel Monréal, José A. Carmona, Eduardo Aguilar, Ramón Coll, Carmen Suárez · 2009 · Medicina Clínica
  42. The dose of aspirin for the prevention of cardiovascular and cerebrovascular events
    Matt Fisher, Volker A. Knappertz · 2006 · Current Medical Research and Opinion
  43. Association of ischemic stroke to coronary artery disease using computed tomography coronary angiography
    Jesper Khedri Jensen, Héctor M. Medina, Bjarne Linde Nørgaard, Kristian Altern Øvrehus, Jesper Møller Jensen, L H Nielsen, Pál Maurovich‐Horvat, Leif‐Christopher Engel, James L. Januzzi, Udo Hoffmann et al. · 2011 · International Journal of Cardiology
  44. Quality Indicators in Cardiovascular Care
    Randal J. Thomas, Brandi J. Witt, Francisco Alejandro López-Jiménez, Marjorie L. King, Ray W. Squires · 2005 · Journal of Cardiopulmonary Rehabilitation
  45. Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study
    Zainali S. Chunawala, Arman Qamar, Sameer Arora, Ambarish Pandey, Marat Fudim, Muthiah Vaduganathan, Deepak L. Bhatt, Robert John Mentz, Melissa C. Caughey · 2022 · Journal of Cardiac Failure
  46. Uninsured South Florida vascular surgery patients are less likely to receive optimal medical management than their insured counterparts.
    Da-Ming Yeh, Monique Jones, C. Schulman, J. Karmacharya, O. Velazquez · 2010 · Journal of Vascular Surgery
  47. Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention
    Lisa Tully, Eugenia Gianos, Anish K. Vani, Yu Guo, Revathi Balakrishnan, Arthur Z. Schwartzbard, James N. Slater, Richard Albert Stein, James A. Underberg, HOWARD S. WEINTRAUB et al. · 2014 · American Heart Journal
  48. Association between Blood Lipid Levels and Personality Traits in Young Korean Women
    Seung-Ju Roh, Han‐Na Kim, Unjin Shim, Bohye Kim, Su‐jin Kim, Hye Won Chung, Hyejin Lee, Yeon‐Ah Sung, Hyung‐Lae Kim · 2014 · PLoS ONE
  49. Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study
    Jisheng S. Cui, Andrew Benjamin Forbes, Adrienne C Kirby, John R. Simes, Andrew Maxwell Tonkin · 2009 · European Journal of Cardiovascular Prevention & Rehabilitation
  50. Impact of Coaching Patients on Coronary Risk Factors
    Margarite J. Vale, Michael V Jelinek, James Donovan Best · 2005 · Disease Management & Health Outcomes
  51. Perceived barriers to physical activity among Nigerian stroke survivors
    Opeyemi Ayodiipo Idowu, Ade Fatai Adeniyi, Omoyemi O. Ogwumike, Henrietta O. Fawole, Olayinka Akinrolie · 2015 · Pan African Medical Journal
  52. Comparison of Secondary Prevention Care after Myocardial Infarction and Stroke
    Eric M. Cheng, Alex Chen, Stefanie D. Vassar, Martin Lee, Stanley N. Cohen, Barbara G. Vickrey · 2006 · Cerebrovascular Diseases
  53. Subcutaneous Oxygen Pressure in Spontaneously Breathing Lean and Obese Volunteers: a Pilot Study
    Luzius B. Hiltebrand, Heiko A. Kaiser, Dagmar J. Niedhart, Gunther Pestel, Andrea M. Kurz · 2007 · Obesity Surgery
  54. Impact of a Nurse Telephone Intervention Among High-Cardiovascular-Risk, Health Fair Participants
    Lisa H Jensen, Bonnie A. Leeman-Castillo, Stephanie M. Coronel, Darryl Perry, Cindy Belz, Craig Kapral, Mori Jacob Krantz · 2009 · The Journal of Cardiovascular Nursing
  55. Obesity dilemma in the global burden of cardiovascular diseases
    Marko Boban, Viktor Peršić, Željko Jovanović, Alenka Brozina, Bojan Miletić, Ante Rotim, Nikša Drinković, Šime Manola, Gordana Laškarin, Luka Boban · 2013 · International Journal of Clinical Practice
  56. Risk factors for the progression of periodontal disease in a Greek adult population
    Nikolaos Andreas Chrysanthakopoulos · 2015 · Journal of Investigative and Clinical Dentistry
  57. Implementation of case management to reduce cardiovascular disease risk in the Stanford and San Mateo Heart to Heart randomized controlled trial: study protocol and baseline characteristics
    Jun Ma, Ky‐Van Lee, Kathy A. Berra, Randall Scott Stafford · 2006 · Implementation Science
  58. Task Force #3—getting results: who, where, and how?
    Philip A. Ades, Thomas E. Kottke, Nancy Houston Miller, John Christie McGrath, N. Burgess Record, Sandra S. Record · 2002 · Journal of the American College of Cardiology
  59. Protecting the heart: a practical review of the statin studies.
    Ong Ht · 2002 · PubMed
  60. Atherosclerosis Imaging and the Future of Lipid Management
    Scott M. Grundy · 2004 · Circulation
  61. Beta-blockers for preventing stroke recurrence
    Luiz Gustavo De Lima, Bernardo GO Soares, Humberto Saconato, Álvaro Nagib Atallah, Edina MK da Silva · 2013 · Cochrane Database of Systematic Reviews
  62. Statin Use Following Hospitalization Among Medicare Beneficiaries With a Secondary Discharge Diagnosis of Acute Myocardial Infarction
    Huifeng Yun, Monika M. Safford, Todd M. Brown, Michael E. Farkouh, Shia T. Kent, Pradeep Sharma, Meredith L. Kilgore, Vera Bittner, Robert S. Rosenson, Elizabeth Delzell et al. · 2015 · Journal of the American Heart Association
  63. Cardiovascular Disease in Chinese Women
    Yingjuan Cao, Michelle L DiGiacomo, Huiyun Du, Eirwyn Ollerton, Patricia Mary Davidson · 2008 · The Journal of Cardiovascular Nursing
  64. Entraînement à l'effort au cours des pathologies cardiovasculaires
    Jean-Marie Casillas, Vincent Grémeaux, Sabeur Damak, A. Feki, Dominic Alain Pérennou · 2007 · Annales de Réadaptation et de Médecine Physique
  65. Frequency of undiagnosed and untreated diabetes mellitus in patients with acute coronary syndromes
    Darcy Green Conaway, James Henry O’Keefe · 2006 · Expert Review of Cardiovascular Therapy
  66. Cardiovascular Risk Factor Profiles and Endothelial Function in Coronary Artery Disease Patients Treated with Statins
    Yoshifumi Okura, Makiko TAKAO, Bo Zhang, Yoshiyuki Nakashima, Keijiro Saku · 2004 · Hypertension Research
  67. Improving Outcomes for Acute Coronary Syndrome Patients in the Hospital Setting
    Frances M. Flynn, Mary Cafarelli, Karen Petrakos, Patricia Christophersen · 2007 · The Journal of Cardiovascular Nursing
  68. Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment
    Leila Fernandes Araújo, Alexandre de Matos Soeiro, J. Fernandes, Antonio E Pesaro, C. Serrano · 2006 · Vascular Health and Risk Management
  69. Assessment of and physician response to glycemic control in diabetic patients presenting with an acute coronary syndrome
    Darcy Green Conaway, Jonathan R. Enriquez, J. Barberena, Philip G. Jones, James Henry O’Keefe, John A. Spertus · 2006 · American Heart Journal
  70. Cardiovascular secondary prevention: patients' knowledge of cardiovascular risk factors and their attitude to reduce the risk burden, and the practice of family doctors. The "Help Your Heart Stay Young" study.
    Aldo Celentano, Vittorio Palmieri, Emma Arezzi, Maria Sabatella, Bruno Guillaro, Ciro Brancati, Gaetano Piccinocchi, Stefana Minichiello, Cesare Russo, Salvatore Pezzullo et al. · 2004 · PubMed
  71. The effect of combined treatment with Impella® and landiolol in a swine model of acute myocardial infarction
    Isamu Yoshitake, Mitsumasa Hata, Akira Sezai, Satoshi Unosawa, Shinji Wakui, Haruka Kimura, Kin‐ichi Nakata, Hiroaki Hata, Motomi Shiono · 2012 · Journal of Artificial Organs
  72. Ovarian Metabolic activity in Dehydroepiandrosterone-Induced Polycystic Ovary in Wistar rats Treated with Aspirin
    Olugbemi Tope Olaniyan, Bamidele Joseph Okoli, Silas Uche, Femi Adebayo, Ayobami Dare, Oluwafemi Ayoola, Modupe Iretiola Builders, Pratap Chand Mali · 2019 · JBRA
  73. Initial Strategy of Revascularization Versus Optimal Medical Therapy for Improving Outcomes in Ischemic Heart Disease: A Review of the Literature
    A. Vincent Songco, Sorin J. Brener · 2012 · Current Cardiology Reports
  74. Low‐Density Lipoprotein Reduction and Magnitude of Cardiovascular Risk Reduction
    Catherine R. Rahilly‐Tierney, Elizabeth V. Lawler, Richard E. Scranton, J. Michael Gaziano · 2009 · Preventive Cardiology
  75. Referrals in Acute Coronary Events for CARdiac Catheterization: The RACE CAR trial
    Catherine Kreatsoulas, Debi A. Sloane, Janice M. Pogue, James L. Velianou, Sonia Savitri Anand · 2010 · Canadian Journal of Cardiology
  76. Cardiac rehabilitation as secondary prevention center
    Vera Bittner, Bonnie Sanderson · 2006 · Coronary Artery Disease
  77. Statin therapy after acute myocardial infarction: Are we adequately treating high-risk patients?
    Gregg C. Fonarow · 2002 · Current Atherosclerosis Reports
  78. Reducing the Knowledge‐Practice Gap in the Management of Patients With Cardiovascular Disease
    Ezra A. Amsterdam, Lawrence J. Laslett, Deborah B. Diercks, J. Douglas Kirk · 2002 · Preventive Cardiology
  79. Impact of heart disease and quality of care on minority populations in the United States.
    Garth Nigel Graham, Mayadallia Guendelman, Benjamin S. H. Leong, Sara Hogan, Adrienne Dennison · 2006 · PubMed Central
  80. Postoperative Statin Therapy Attenuates the Intensity of Systemic Inflammation and Increases Fibrinolysis After Coronary Artery Bypass Grafting
    Şermin Tetik, Koray Ak, Yucel Sahin, Ozkan Gulsoy, Selim İşbir, Sinan Arsan, Turay Yardımcı · 2010 · Clinical and Applied Thrombosis/Hemostasis
  81. Endoscopic Ulcer Rates in Healthy Subjects Associated with Use of Aspirin (81 mg q.d.) Alone or Coadministered with Celecoxib or Naproxen: A randomized, 1-Week Trial
    Jay L. Goldstein, James Aisenberg, Salam F. Zakko, Manuela F. Berger, William E. Dodge · 2007 · Digestive Diseases and Sciences
  82. Non-invasive cardiac assessment in high risk patients (The GROUND study): rationale, objectives and design of a multi-center randomized controlled clinical trial
    Alexander M. de Vos, Annemarieke Rutten, Hester J. van der Zaag–Loonen, Michiel L. Bots, Riksta Dikkers, Robert A Buiskool, Willem P.Th.M. Mali, Daniel D. Lubbers, Arend Mosterd, Mathias Prokop et al. · 2008 · Trials
  83. Improving Cardiovascular Care Through Outpatient Cardiac Rehabilitation
    Holly Mead, Sarah Grantham, Bruce Siegel · 2013 · The Journal of Cardiovascular Nursing
  84. Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice
    Sanjay K Gandhi, Krister Järbrink, Kathleen M. Fox, Gunnar Brandrup‐Wognsen · 2009 · Current Medical Research and Opinion
  85. Use of Antihypertensive Drug Therapy in Older Persons in an Academic Nursing Home
    Valerie Ziesmer, Subrata Ghosh, Wilbert S. Aronow · 2003 · Journal of the American Medical Directors Association
  86. Atherosclerosis imaging for risk assessment and primary prevention of cardiovascular disease
    Scott M. Grundy · 2003 · Progress in Cardiovascular Diseases
  87. Optimizing treatment of diabetes and cardiovascular disease with combined α,β‐blockade
    David S.H. Bell · 2005 · Current Medical Research and Opinion
  88. Functional, Nutraceutical and Health Endorsing Perspectives of Saffron
    Tabussam Tufail, Huma Bader Ul Ain, Ali Ikram, Muhammad Tayyab Arshad, Muhammed Adem Abdullahi · 2025 · Food Science & Nutrition
  89. Demographics of carotid atherosclerotic plaque features imaged by computed tomography
    Jeffrey D. Chien, Andre Furtado, Su‐Chun Cheng, Jessica Lam, Sarah Schaeffer, Kimberly Chun, Max Wintermark · 2013 · Journal of Neuroradiology
  90. Microalbuminuria, macroalbuminuria and uncontrolled blood pressure among diagnosed hypertensive patients: the aspect of racial disparity in the NHANES study
    Xuefeng Liu, Kesheng Wang, Liang Wang, Dennis Tsilimingras · 2013 · Hypertension Research
  91. Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis
    Molly D. Magnano, Mark C. Genovese · 2005 · Current Rheumatology Reports
  92. Moderate-carbohydrate low-fat versus low-carbohydrate high-fat meal replacements for weight loss
    Jillon S. Vander Wal, Michael I. McBurney, Nancy Moellering, Jorene M. Marth, Nikhil V. Dhurandhar · 2007 · International Journal of Food Sciences and Nutrition
  93. Modifying women's risk for cardiovascular disease.
    K. Mccauley · 2007 · Journal of Obstetric, Gynecologic and Neonatal Nursing
  94. Improving Functional Status and Quality of Life in Elderly Patients with Peripheral Arterial Disease
    Lois A. Killewich · 2005 · Journal of the American College of Surgeons
  95. Management of the Elderly Person After Myocardial Infarction
    Wilbert S. Aronow · 2004 · The Journals of Gerontology Series A
  96. Assessment of Compliance with Lipid Guidelines in an Academic Medical Center
    Sarah J Schwiesow, Jean M. Nappi, Kelly R. Ragucci · 2005 · Annals of Pharmacotherapy
  97. Vulnerable plaque intervention: State of the art
    John J. Young, Harry R. Phillips, Steven P. Marso, Juan F. Granada, John McPherson, Ron Waksman, Steven R. Steinhubl, Robert S. Schwartz, Gregg W. Stone · 2008 · Catheterization and Cardiovascular Interventions
  98. Cardiovascular Disease
    Dan Sorescu, NANETTE KASS WENGER · 2004 · Springer eBooks
  99. High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study
    Meyer Elbaz, Julien Faccini, Vanina Bongard, Cécile Ingueneau, Dorotea Taraszkiewicz, Bertrand Perret, Jean Ferrières, Jean‐Bernard Ruidavets, Cécile Vindis · 2016 · Archives of cardiovascular diseases
  100. Practical ways to deal with the high burden of cardiovascular disease in hemodialysis patients
    José Jayme G. De Lima · 2006 · Sao Paulo Medical Journal